Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

83 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Gene therapy for diabetes: reinventing the islet.
Samson SL, Chan L. Samson SL, et al. Trends Endocrinol Metab. 2006 Apr;17(3):92-100. doi: 10.1016/j.tem.2006.02.002. Epub 2006 Feb 28. Trends Endocrinol Metab. 2006. PMID: 16504534 Review.
Gene therapy for diabetes: metabolic effects of helper-dependent adenoviral exendin 4 expression in a diet-induced obesity mouse model.
Samson SL, Gonzalez EV, Yechoor V, Bajaj M, Oka K, Chan L. Samson SL, et al. Mol Ther. 2008 Nov;16(11):1805-12. doi: 10.1038/mt.2008.198. Epub 2008 Sep 9. Mol Ther. 2008. PMID: 18781141 Free PMC article.
The Kr├╝ppel-like zinc finger protein Glis3 directly and indirectly activates insulin gene transcription.
Yang Y, Chang BH, Samson SL, Li MV, Chan L. Yang Y, et al. Among authors: samson sl. Nucleic Acids Res. 2009 May;37(8):2529-38. doi: 10.1093/nar/gkp122. Epub 2009 Mar 5. Nucleic Acids Res. 2009. PMID: 19264802 Free PMC article.
Gene therapy with neurogenin 3 and betacellulin reverses major metabolic problems in insulin-deficient diabetic mice.
Yechoor V, Liu V, Paul A, Lee J, Buras E, Ozer K, Samson S, Chan L. Yechoor V, et al. Among authors: samson s. Endocrinology. 2009 Nov;150(11):4863-73. doi: 10.1210/en.2009-0527. Epub 2009 Oct 9. Endocrinology. 2009. PMID: 19819964 Free PMC article.
Effects of combined exenatide and pioglitazone therapy on hepatic fat content in type 2 diabetes.
Sathyanarayana P, Jogi M, Muthupillai R, Krishnamurthy R, Samson SL, Bajaj M. Sathyanarayana P, et al. Among authors: samson sl. Obesity (Silver Spring). 2011 Dec;19(12):2310-5. doi: 10.1038/oby.2011.152. Epub 2011 Jun 9. Obesity (Silver Spring). 2011. PMID: 21660077 Clinical Trial.
GLP-1R agonist therapy for diabetes: benefits and potential risks.
Samson SL, Garber A. Samson SL, et al. Curr Opin Endocrinol Diabetes Obes. 2013 Apr;20(2):87-97. doi: 10.1097/MED.0b013e32835edb32. Curr Opin Endocrinol Diabetes Obes. 2013. PMID: 23403741 Review.
Metabolic syndrome.
Samson SL, Garber AJ. Samson SL, et al. Endocrinol Metab Clin North Am. 2014 Mar;43(1):1-23. doi: 10.1016/j.ecl.2013.09.009. Endocrinol Metab Clin North Am. 2014. PMID: 24582089 Review.
Cardiovascular effects of incretin therapy in diabetes care.
Kim J, Samson SL. Kim J, et al. Among authors: samson sl. Metab Syndr Relat Disord. 2014 Aug;12(6):303-10. doi: 10.1089/met.2014.0035. Epub 2014 May 19. Metab Syndr Relat Disord. 2014. PMID: 24842063 Free PMC article. Review.
Prevention of type 2 Diabetes Mellitus: Potential of pharmacological agents.
Samson SL, Garber AJ. Samson SL, et al. Best Pract Res Clin Endocrinol Metab. 2016 Jun;30(3):357-71. doi: 10.1016/j.beem.2016.06.005. Epub 2016 Jun 15. Best Pract Res Clin Endocrinol Metab. 2016. PMID: 27432071 Review.
Obestatin stimulates glucose-induced insulin secretion through ghrelin receptor GHS-R.
Pradhan G, Wu CS, Han Lee J, Kanikarla P, Guo S, Yechoor VK, Samson SL, Sun Y. Pradhan G, et al. Among authors: samson sl. Sci Rep. 2017 Apr 20;7(1):979. doi: 10.1038/s41598-017-00888-0. Sci Rep. 2017. PMID: 28428639 Free PMC article.
83 results
Jump to page
Feedback